Document Detail


Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid.
MedLine Citation:
PMID:  6211133     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Piperacillin, a new semisynthetic penicillin, was evaluated for efficacy and safety in 26 patients, most of whom had pneumonia. Included were four patients with gram-negative meningitis in whom the penetration of piperacillin into cerebrospinal fluid was determined. Cure was achieved in 11 of 17 patients with pneumonia; another 4 were improved. One relapse and one failure occurred among nine patients with gram-negative pneumonia. Cure or improvement occurred in seven of nine patients with gram-negative infection in various extrapulmonary sites. Piperacillin given by continuous infusion in a dosage ranging from 324 to 436 mg/kg of body weight per day to four patients with meningitis resulted in a mean cerebrospinal fluid level of 23 micrograms/ml at 24 h; the mean penetration of piperacillin into the cerebrospinal fluid was 32% at this interval. Levels of piperacillin in cerebrospinal fluid collected later during the course of therapy were also adequate. Adverse effects were noted in six patients, but only one episode of granulocytopenia was serious. Emergence of resistance to piperacillin did not occur, and only one superinfection was noted. Piperacillin appeared to be efficacious in the treatment of pneumonia. It penetrated well into the cerebrospinal fluid of patients with meningitis and may be useful for treatment of selected gram-negative infections in extrapulmonary sites.
Authors:
G M Dickinson; D G Droller; R L Greenman; T A Hoffman
Related Documents :
14556753 - Circulating levels of granulocyte macrophage colony-stimulating factor in patients with...
12960693 - Polymerase chain reaction on cerebrospinal fluid cells in suspected leptomeningeal invo...
14648413 - Prevalence and significance of periduodenal venous collaterals in patients evaluated fo...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  20     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  1981 Oct 
Date Detail:
Created Date:  1982-07-08     Completed Date:  1982-07-08     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  481-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Haemophilus Infections / drug therapy
Humans
Klebsiella Infections / drug therapy
Meningitis / drug therapy
Penicillins / blood,  cerebrospinal fluid,  therapeutic use*
Piperacillin
Pneumonia / drug therapy
Pneumonia, Pneumococcal / drug therapy
Pseudomonas Infections / drug therapy
Chemical
Reg. No./Substance:
0/Penicillins; 61477-96-1/Piperacillin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A life table for onset of Huntington's chorea.
Next Document:  Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibi...